High MiR-200a-3p Expression Has High Diagnostic Values for Hypertensive Disorders Complicating Pregnancy and Predicts Adverse Pregnancy Outcomes

Overview

Journal BMC Pregnancy Childbirth

Publisher Biomed Central

Specialty Gynecology & Obstetrics

Date 2022 Jun 15

PMID 35705894

Authors

Xin He

Danni Ding

Affiliations

Soon will be listed here.

Abstract

Background: Hypertensive disorders complicating pregnancy (HDCP) are various heterogeneous conditions. microRNA (miR)-200a-3p is involved in HDCP diagnosis. This study explored the effects of miR-200a-3p on HDCP patients.

Methods: A total of 126 singleton HDCP patients including 50 cases of gestation hypertension (GH), 42 cases of mild preeclampsia (MP) and 34 cases of severe preeclampsia (SP), were enrolled as study subjects, and 50 normal pregnant women were selected as the control. Serum miR-200a-3p expression was detected and its efficacy in HDCP diagnosis and grading was evaluated. GH, MP and SP patients were allocated to high/low miR-200a-3p expression groups. The correlation between miR-200a-3p expression and general clinical indexes was analyzed. HDCP patients were allocated to high/low miR-200a-3p expression group and maternal and fetal outcomes were followed up. Effects of miR-200a-3p expression on adverse pregnancy outcome incidence were analyzed.

Results: miR-200a-3p expression in the serum of HDCP patients was upregulated. The sensitivity and specificity of serum miR-200a-3p level > 1.201 were 87.3% and 96.0%, respectively. Serum miR-200a-3p level in GH, MP and SP patients was increased with the aggravation of the disease. The cut-off value and area under the curve (AUC) of miR-200a-3p for GH, MP and SP diagnosis were 1.145 and 0.9094 (82.0% sensitivity and 88.0% specificity), 1.541 and 0.8126 (73.8% sensitivity and 76.0% specificity), and 1.866 and 0.7367 (64.7% sensitivity and 76.2% specificity), respectively. Serum miR-200a-3p level was correlated with general clinical indexes, fetal birth weight, systolic to diastolic ratio, and fetal growth restriction incidence. High serum miR-200a-3p expression in HDCP patients was associated with increased adverse pregnancy outcomes.

Conclusion: High miR-200a-3p expression could help to diagnose HDCP, judge severity and was associated with increased adverse pregnancy outcomes.

Citing Articles

Exploring the Role of miRNA-101a in the Circulatory System's Adaptive Mechanisms in Hypertensive Disorders of Pregnancy.

Szczerba E, Kozyra-Pydys E, Zajkowska A, Pankiewicz K, Szewczyk G, Maciejewski T Diagnostics (Basel). 2025; 15(5).

PMID: 40075783 PMC: 11899601. DOI: 10.3390/diagnostics15050535.

Non-coding RNAs regulating mitochondrial function in cardiovascular diseases.

Ao X, Ding W, Li X, Xu Q, Chen X, Zhou X J Mol Med (Berl). 2023; 101(5):501-526.

PMID: 37014377 DOI: 10.1007/s00109-023-02305-8.

Extracellular Non-Coding RNAs in Cardiovascular Diseases.

Jiapaer Z, Li C, Yang X, Sun L, Chatterjee E, Zhang L Pharmaceutics. 2023; 15(1).

PMID: 36678784 PMC: 9865796. DOI: 10.3390/pharmaceutics15010155.

References

Mei Z, Huang B, Mo Y, Fan J . An exploratory study into the role of miR-204-5p in pregnancy-induced hypertension. Exp Ther Med. 2017; 13(5):1711-1718. PMC: 5443271. DOI: 10.3892/etm.2017.4212. View

Araki Y, Yanagida M . Hypertensive disorders of pregnancy: Strategy to develop clinical peptide biomarkers for more accurate evaluation of the pathophysiological status of this syndrome. Adv Clin Chem. 2020; 94:1-30. DOI: 10.1016/bs.acc.2019.07.007. View

Murphy M, Casselman R, Tayade C, Smith G . Differential expression of plasma microRNA in preeclamptic patients at delivery and 1 year postpartum. Am J Obstet Gynecol. 2015; 213(3):367.e1-9. DOI: 10.1016/j.ajog.2015.05.013. View

Wu G, Jin Y, Cao Y, Li J . The diagnostic value and regulatory mechanism of miR-200a targeting in pregnancy-induced hypertension. Hypertens Pregnancy. 2020; 39(3):243-251. DOI: 10.1080/10641955.2020.1757700. View

Burwick R, Rincon M, Beeraka S, Gupta M, Feinberg B . Evaluation of Hemolysis as a Severe Feature of Preeclampsia. Hypertension. 2018; 72(2):460-465. DOI: 10.1161/HYPERTENSIONAHA.118.11211. View

Shah S, Gupta A . Hypertensive Disorders of Pregnancy. Cardiol Clin. 2019; 37(3):345-354. DOI: 10.1016/j.ccl.2019.04.008. View

Kasraeian M, Asadi N, Vafaei H, Zamanpour T, Raeisi Shahraki H, Bazrafshan K . Evaluation of serum biomarkers for detection of preeclampsia severity in pregnant women. Pak J Med Sci. 2018; 34(4):869-873. PMC: 6115551. DOI: 10.12669/pjms.344.14393. View

Kolkova Z, Holubekova V, Grendar M, nachajova M, Zubor P, Pribulova T . Association of Circulating miRNA Expression with Preeclampsia, Its Onset, and Severity. Diagnostics (Basel). 2021; 11(3). PMC: 8001188. DOI: 10.3390/diagnostics11030476. View

Corsello S, Paragliola R . Evaluation and Management of Endocrine Hypertension During Pregnancy. Endocrinol Metab Clin North Am. 2019; 48(4):829-842. DOI: 10.1016/j.ecl.2019.08.011. View

10.

Agrawal A, Wenger N . Hypertension During Pregnancy. Curr Hypertens Rep. 2020; 22(9):64. DOI: 10.1007/s11906-020-01070-0. View

11.

Harrington W, Moore K, Min A, Gilder M, Tun N, Paw M . Falciparum but not vivax malaria increases the risk of hypertensive disorders of pregnancy in women followed prospectively from the first trimester. BMC Med. 2021; 19(1):98. PMC: 8077872. DOI: 10.1186/s12916-021-01960-3. View

12.

Su M, Tsai P, Wang C, Tsai H, Kuo P . Aspirin facilitates trophoblast invasion and epithelial-mesenchymal transition by regulating the miR-200-ZEB1 axis in preeclampsia. Biomed Pharmacother. 2021; 139:111591. DOI: 10.1016/j.biopha.2021.111591. View

13.

Antza C, Cifkova R, Kotsis V . Hypertensive complications of pregnancy: A clinical overview. Metabolism. 2017; 86:102-111. DOI: 10.1016/j.metabol.2017.11.011. View

14.

Zhu L, Liu Z . Serum from patients with hypertension promotes endothelial dysfunction to induce trophoblast invasion through the miR‑27b‑3p/ATPase plasma membrane Ca transporting 1 axis. Mol Med Rep. 2021; 23(5). PMC: 7974411. DOI: 10.3892/mmr.2021.11958. View

15.

Sutton A, Harper L, Tita A . Hypertensive Disorders in Pregnancy. Obstet Gynecol Clin North Am. 2018; 45(2):333-347. DOI: 10.1016/j.ogc.2018.01.012. View

16.

Filipek A, Jurewicz E . [Preeclampsia - a disease of pregnant women]. Postepy Biochem. 2019; 64(4):232-229. DOI: 10.18388/pb.2018_146. View

17.

Renthal N, Chen C, Williams K, Gerard R, Prange-Kiel J, Mendelson C . miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc Natl Acad Sci U S A. 2010; 107(48):20828-33. PMC: 2996411. DOI: 10.1073/pnas.1008301107. View

18.

Bounds K, Chiasson V, Pan L, Gupta S, Chatterjee P . MicroRNAs: New Players in the Pathobiology of Preeclampsia. Front Cardiovasc Med. 2017; 4:60. PMC: 5622156. DOI: 10.3389/fcvm.2017.00060. View

19.

Wang C, Tsai P, Chen T, Tsai H, Kuo P, Su M . Elevated miR-200a and miR-141 inhibit endocrine gland-derived vascular endothelial growth factor expression and ciliogenesis in preeclampsia. J Physiol. 2019; 597(12):3069-3083. DOI: 10.1113/JP277704. View

20.

Williams K, Renthal N, Condon J, Gerard R, Mendelson C . MicroRNA-200a serves a key role in the decline of progesterone receptor function leading to term and preterm labor. Proc Natl Acad Sci U S A. 2012; 109(19):7529-34. PMC: 3358858. DOI: 10.1073/pnas.1200650109. View